The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for global pharmaceutical trends.
Ferring has bundled the European and Canadian markets into one single region. Could you please introduce us to the full scope of your role and explain why the European and Canadian markets are considered to be one region?
I believe that it is a rather standard grouping within the pharmaceutical industry. The market access system in Canada is similar to the market access system in Europe in terms of negotiations with the payer as well as public governance for instance. Hence why it makes sense to regroup Canada with Europe rather than with the USA.
The beauty of working in midsized companies is the flat organization. You are aware of the number of people involved and decision making is a short process
